AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Accounts payable

annual accounts payable:

$2.94M-$19.12M(-86.68%)
December 31, 2024

Summary

  • As of today (September 18, 2025), AMLX annual accounts payable is $2.94 million, with the most recent change of -$19.12 million (-86.68%) on December 31, 2024.
  • During the last 3 years, AMLX annual accounts payable has fallen by -$1.43 million (-32.78%).
  • AMLX annual accounts payable is now -86.68% below its all-time high of $22.06 million, reached on December 31, 2023.

Performance

AMLX Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

quarterly accounts payable:

$3.29M-$1.52M(-31.52%)
June 1, 2025

Summary

  • As of today (September 18, 2025), AMLX quarterly accounts payable is $3.29 million, with the most recent change of -$1.52 million (-31.52%) on June 1, 2025.
  • Over the past year, AMLX quarterly accounts payable has dropped by -$1.66 million (-33.52%).
  • AMLX quarterly accounts payable is now -86.66% below its all-time high of $24.70 million, reached on June 30, 2023.

Performance

AMLX quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

AMLX Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-86.7%-33.5%
3 y3 years-32.8%-59.4%
5 y5 years+33.9%-8.8%

AMLX Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-86.7%at low-86.7%+121.5%
5 y5-year-86.7%+33.9%-86.7%+121.5%
alltimeall time-86.7%+33.9%-86.7%+121.5%

AMLX Accounts payable History

DateAnnualQuarterly
Jun 2025
-
$3.29M(-31.5%)
Mar 2025
-
$4.81M(+63.7%)
Dec 2024
$2.94M(-86.7%)
$2.94M(+97.6%)
Sep 2024
-
$1.49M(-70.0%)
Jun 2024
-
$4.96M(-76.9%)
Mar 2024
-
$21.45M(-2.8%)
Dec 2023
$22.06M
$22.06M(+246.3%)
Sep 2023
-
$6.37M(-74.2%)
DateAnnualQuarterly
Jun 2023
-
$24.70M(+129.3%)
Mar 2023
-
$10.77M(+72.1%)
Dec 2022
$6.26M(+43.1%)
$6.26M(-11.3%)
Sep 2022
-
$7.05M(-13.1%)
Jun 2022
-
$8.12M(-19.2%)
Mar 2022
-
$10.04M(+129.8%)
Dec 2021
$4.37M(+21.0%)
$4.37M(+21.0%)
Dec 2020
$3.61M(+64.6%)
$3.61M
Dec 2019
$2.19M
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual accounts payable?
  • What is the all time high annual accounts payable for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual accounts payable year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual accounts payable?

The current annual accounts payable of AMLX is $2.94M

What is the all time high annual accounts payable for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual accounts payable is $22.06M

What is Amylyx Pharmaceuticals, Inc. annual accounts payable year-on-year change?

Over the past year, AMLX annual accounts payable has changed by -$19.12M (-86.68%)

What is Amylyx Pharmaceuticals, Inc. quarterly accounts payable?

The current quarterly accounts payable of AMLX is $3.29M

What is the all time high quarterly accounts payable for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly accounts payable is $24.70M

What is Amylyx Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?

Over the past year, AMLX quarterly accounts payable has changed by -$1.66M (-33.52%)
On this page